Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients

American Journal of Hematology
Veronika Buxhofer-AuschTiziano Barbui

Abstract

We aimed to determine risk factors for thrombotic events in early/prefibrotic myelofibrosis diagnosed according to the World Health Organization criteria. Multivariate Cox regression analysis was calculated on a total number of 264 patients derived from an international database. After a median follow-up of 6.28 years, 42 (15.9%) patients experienced arterial (n = 31) or venous thrombosis (n = 11). A higher leukocyte count correlated with an increased risk for total thrombosis and in particular, with an increased risk for arterial thrombosis (P = 0.005, HR 1.15 and P = 0.047, HR 1.12, respectively). A platelet count above 870 × 10⁹/L was associated with a lower risk for total thrombosis and also for venous thrombosis (P = 0.022, HR 0.44 and P = 0.027, HR 0.19). Moreover, a lower hemoglobin level was associated with an increased risk for venous thrombosis (P = 0.007, HR 0.59). Our data indicate that leukocytosis is a prominent risk factor for thrombosis in early/prefibrotic MF.

References

Feb 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roberto MarchioliTiziano Barbui
Dec 8, 2009·Blood·Tiziano BarbuiGiovanni Barosi
Jul 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiziano BarbuiAyalew Tefferi

❮ Previous
Next ❯

Citations

Sep 6, 2014·Best Practice & Research. Clinical Haematology·Giovanni Barosi
Jan 11, 2016·Journal of Veterinary Emergency and Critical Care·Vincent J ThawleyLesley G King
Apr 23, 2013·Journal of Thrombosis and Haemostasis : JTH·A CasiniT P Lecompte
May 15, 2013·Expert Opinion on Pharmacotherapy·Gunnar Birgegård
Jul 8, 2016·Journal of Thrombosis and Thrombolysis·Margarita KushnirHenny H Billett
Apr 1, 2018·European Journal of Haematology·Veronika Buxhofer-AuschHeinz Gisslinger
Jun 5, 2018·Expert Review of Hematology·Elisa RumiUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Feb 6, 2020·Journal of Thrombosis and Haemostasis : JTH·Walid SalibaMeir Preis
Apr 7, 2020·Expert Review of Hematology·Thomas Sau-Yan ChanEric Tse
May 14, 2020·Current Hematologic Malignancy Reports·Carlos Galvez, Brady L Stein
Feb 27, 2020·Blood Cancer Journal·Paola GuglielmelliTiziano Barbui
Nov 9, 2018·Blood Cancer Journal·Guido FinazziTiziano Barbui
Aug 16, 2017·Annals of Hematology·Devendra KcSrdan Verstovsek
Sep 28, 2017·Current Hematologic Malignancy Reports·Karlyn Martin
Jun 28, 2018·Blood Cancer Journal·Valerio De StefanoTiziano Barbui
Feb 16, 2021·Hämostaseologie·Anna FalangaFrancesca Schieppati
Dec 27, 2017·Clinical Lymphoma, Myeloma & Leukemia·Prithviraj BoseSrdan Verstovsek
Apr 13, 2018·Science Translational Medicine·Ofir WolachBenjamin L Ebert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.